13C-Acetate Magnetic Resonance Spectroscopy to Test for Susceptibility to Hypoglycemia
This technology is a novel biomarker that has a strong potential use as a clinical diagnostic test for assessing hypoglycemic risk in persons with diabetes.
Hypoglycemia exposure is associated with increased risk of cardia arrhythmias, sudden cardiac arrest and serious neurological complications such as confusion, seizure, loss of consciousness, coma and brain death.
